Alimentary mucositis: putting the guidelines into practice

  • Michael T. Brennan
  • Inger von Bültzingslöwen
  • Mark M. Schubert
  • Dorothy Keefe
Review Article

Abstract

Background

The Mucositis Study Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology completed an evidence-based review of the literature for the management of alimentary mucositis.

Discussion

The present manuscript puts these guidelines into clinical practice by presenting two cases of alimentary mucositis from cancer therapy. These cases illustrate the impact of oral and gastrointestinal mucositis on patient care.

Keywords

Mucositis (oral, gastrointestinal, alimentary) Mouth Cancer therapy Chemotherapy Radiotherapy Mucosal barrier injury Mucositis management 

References

  1. 1.
    Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, Bekele BN, Raber-Durlacher J, Donnelly JP, Rubenstein EB (2004) Mucositis study section of the Multinational Association for Supportive Care in Cancer; International Society of Oral Oncology. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100(Suppl 9):1995–2025PubMedCrossRefGoogle Scholar
  2. 2.
    Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, Elting LS, Fox PC, Cooksley C, Sonis ST (2004) Mucositis study section of the Multinational Association for Supportive Care in Cancer; International Society for Oral Oncology. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100(Suppl 9):2026–2046PubMedCrossRefGoogle Scholar
  3. 3.
    Borowski B, Benhamou E, Pico JL, Laplanche A, Margainaud JP, Hayat M (1994) Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomised controlled trial comparing two protocols of dental care. Eur J Cancer Part B Oral Oncol 30B(2):93–97CrossRefGoogle Scholar
  4. 4.
    World Health Organization (1979) WHO handbook for reporting results of cancer treatment. World Health Organization, GenevaGoogle Scholar
  5. 5.
    Spielberger R, Stiff P, Bensinger W, Gentile T, Weisdorf D, Kewalramani T, Shea T, Yanovich S, Hansen K, Noga S, McCarty J, LeMaistre CF, Sung EC, Blazar BR, Elhardt D, Chen MG, Emmanouilides C (2004) Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 351(25):2590–2598PubMedCrossRefGoogle Scholar
  6. 6.
    Schubert MM, Peterson DE, Lloid ME (2004) Oral complications. In: Blume KG, Forman SJ, Appelabum FR (eds) Hematopoietic cell transplantation. Blackwell, Cambridge, pp 911–928Google Scholar
  7. 7.
    Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J, Hayden V, Eilers J, Epstein JB, LeVeque FG, Miller C, Peterson DE, Schubert MM, Spijkervet FK, Horowitz M (2001) Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 19(8):2201–2205PubMedGoogle Scholar
  8. 8.
    Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB (2003) The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 98(7):1531–1539PubMedCrossRefGoogle Scholar
  9. 9.
    Lenssen P, Aker SN (2002) Adult hematopoietic stem cell transplantation. In: Hasse JM, Blue LS (eds) Comprehensive guide to transplant nutrition. American Dietetic Association, Chicago, pp 123–151Google Scholar
  10. 10.
    ASPEN Board of Directors and the Clinical Guidelines Task Force (2002) Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr 26(Suppl 1):1SA–138SAGoogle Scholar
  11. 11.
    Barrera R (2002) Nutritional support in cancer patients. JPEN J Parenter Enteral Nutr 26(Suppl 5):S63–71PubMedCrossRefGoogle Scholar
  12. 12.
    National Cancer Institute Common Toxicity Criteria (1999) Version 2.0, 1999. Available at http://ctep.info.nih.gov. Cited 8 Feb 2006
  13. 13.
    Sartori S, Trevisani L, Nielsen I, Tassinari D, Abbsciano V (1996) Misoprostol and omeprazole in the prevention of chemotherapy-induced acute gastroduodenal mucosal injury. A randomized, placebo-controlled pilot study. Cancer 78(7):1477–1482PubMedCrossRefGoogle Scholar
  14. 14.
    Sartori S, Trevisani L, Nielsen I, Tassinari D, Panzini I, Abbasciano V (2000) Randomized trial of omeprazole or ranitidine versus placebo in the prevention of chemotherapy-induced gastroduodenal injury. J Clin Oncol 18(3):463–467PubMedGoogle Scholar
  15. 15.
    Benson AB 3rd, Ajani JA, Catalano RB, Engelking C, Kornblau SM, Martenson JA Jr, McCallum R, Mitchell EP, O’Dorisio TM, Vokes EE, Wadler S (2004) Recommended guidelines for the treatment of cancer treatment-induced diarrhea. J Clin Oncol 22(14):2918–2926PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Michael T. Brennan
    • 1
  • Inger von Bültzingslöwen
    • 2
  • Mark M. Schubert
    • 3
  • Dorothy Keefe
    • 4
  1. 1.Carolinas Medical CenterCharlotteUSA
  2. 2.Göteborg UniversityGöteborgSweden
  3. 3.Fred Hutchinson Cancer Research CenterSeattleUSA
  4. 4.University of AdelaideAdelaideAustralia

Personalised recommendations